Skin cream shows promise in preventing common skin cancers
NCT ID NCT02636569
First seen Jan 22, 2026 · Last updated May 22, 2026 · Updated 15 times
Summary
This study tested whether a topical medication called diclofenac can reverse certain biomarkers in the skin to prevent non-melanoma skin cancers. 24 participants applied the cream once or twice daily to see if it reduced these biomarkers. The goal was to find the best dose for preventing skin cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-MELANOMA SKIN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Alabama at Birmingham Whitaker Clinic
Birmingham, Alabama, 35233, United States
Conditions
Explore the condition pages connected to this study.